Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Unknown 5Recruiting 3Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14Gastrointestinal 9Other 4Lymphoid 4Genitourinary 4Other hematologic neoplasm 3Tumor-Agnostic 2Thoracic 2Plasma cell 2Head & Neck 1Gynecologic 1Endocrine 1Dermatologic 1CNS 1

Conditions

Thyroid Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Motor Activity 1Lymphoma, Non-Hodgkin 1Kidney Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 46pembrolizumab 42Carboplatin 38Magnetic Resonance Spectroscopy 28olaparib 27Specimen Handling 26Cisplatin 23Bevacizumab 20Nivolumab 19Taxes 18Biopsy 16Gemcitabine 13Cyclophosphamide 13durvalumab 12Immunoglobulin G 11Doxorubicin 11Disulfides 11Surveys and Questionnaires 10niraparib 9liposomal doxorubicin 9dostarlimab 9Radiotherapy 8Brachytherapy 8lenvatinib 7fludarabine 7atezolizumab 7Letrozole 7Docetaxel 7cediranib 6Platinum 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Exercise × Gynecologic × Clear all
NCT04000880 2025-06-12

AMPLIFY

University of Alabama at Birmingham

Phase NA Active not recruiting
603 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidPlasma cell

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Non-Hodgkin, Motor Activity, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡